Pathways of gliadin transport in celiac disease

Annals of the New York Academy of Sciences

Volumn 1165, Issue , 2009, Pages 274-278

  Heyman, Martine ^a,b   Menard, Sandrine ^a,b  

^a INSERM   (France)

^b IFR 94   (France)

Author keywords

CD71; Celiac disease; IgA; Immune complexes; Retro transport

Indexed keywords

CD71 ANTIGEN; GLIADIN; IMMUNOGLOBULIN A;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; INTESTINE CELL; PATHOGENESIS; PROTEIN TRANSPORT; TRANSCYTOSIS;

EID: 67249085660     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04032.x     Document Type: Article

References (15)

1. Arentz-Hansen, H., R. Korner, O. Molberg, et al. 2000. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612.
2. Kim, C.Y., H. Quarsten, E. Bergseng, et al. 2004. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. USA 101: 4175-4179.
3. Shan, L., O. Molberg, I. Parrot, et al. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
4. Maiuri, L., A. Picarelli, M. Boirivant, et al. 1996. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroent. 110: 1368-1378.
5. Shidrawi, R.G., P. Day, R. Przemioslo, et al. 1995. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand. J. Gastroenterol. 30: 758-763.
6. Sturgess, R., P. Day, H.J. Ellis, et al. 1994. Wheat peptide challenge in coeliac disease. Lancet 343: 758-761.
7. Hue, S., J.J. Mention, R.C. Monteiro, et al. 2004. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377.
8. Maiuri, L., C. Ciacci, I. Ricciardelli, et al. 2003. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362: 30-37.
9. Przemioslo, R.T., K.E. Lundin, L.M. Sollid, et al. 1995. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 36: 874-879.
10. Mention, J.J., M. Ben Ahmed, B. Begue, et al. 2003. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroent. 125: 730-745.
11. Meresse, B., Z. Chen, C. Ciszewski, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
12. Matysiak-Budnik, T., C. Candalh, C. Dugave, et al. 2003. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroent. 125: 696-707.
13. Drago, S., A.R. El, P.M. Di, et al. 2006. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. 41: 408-419.
14. Moura, I.C., M.N. Centelles, M. Arcos-Fajardo, et al. 2001. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194: 417-425.
15. Matysiak-Budnik, T., I.C. Moura, M. Arcos-Fajardo, et al. 2008. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205: 143-154.